[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.194.190. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
November 1996

Efficacy of Bronchodilator Therapy in Bronchiolitis: A Meta-analysis

Author Affiliations

From the Division of Infectious Diseases and Clinical Epidemiology Unit, The Hospital for Sick Children (Drs Kellner and Wang), Department of Paediatrics and Clinical Epidemiology and Health Care Research Program, University of Toronto (Drs Kellner, Ohlsson, and Wang), and Department of Newborn and Developmental Paediatrics and Perinatal Clinical Epidemiology Unit, Women's College Hospital (Dr Ohlsson), Toronto, Ontario; and Bassett Healthcare Research Institute and The Mary Imogene Bassett Hospital, Cooperstown, NY (Dr Gadomski).

Arch Pediatr Adolesc Med. 1996;150(11):1166-1172. doi:10.1001/archpedi.1996.02170360056009
Abstract

Objective:  To determine if bronchodilators are efficacious in treating bronchiolitis.

Data Sources:  A search of bibliographic databases (MEDLINE, Excerpta Medica, and Reference Update) for bronchiolitis and albuterol or ipratropium bromide, or adrenergic agents or bronchodilator agents. Reference lists were also used.

Study Selection:  Randomized, placebo-controlled trials of bronchodilator treatment in bronchiolitis were selected by 2 investigators. Fifteen of 89 identified publications met the selection criteria.

Data Extraction:  Investigators independently abstracted data for 3 outcomes: clinical score, oxygen saturation, and hospitalization. Clinical score was measured as a dichotomous variable (score±improved) or continuous variable (average score).

Data Synthesis:  For primary analysis, data were pooled from 8 trials of children with first-time wheezing. The effect size for average score was −0.32 (95% confidence interval [CI], −0.54 to −0.11; P<.01), favoring treatment; the relative risk for score±improved was 0.76 (95% CI, 0.60 to 0.95; P=.02), favoring treatment. Bronchodilators had no effect on hospitalization (relative risk, 0.85; 95% CI, 0.47 to 1.53; P=.58), but co-interventions may have been administered prior to this outcome. The results for oxygen saturation were too varied to allow pooling of the results. Secondary analyses were performed on 4 outpatient trials of children with first-time wheezing, 7 trials in which only nebulized β-agonists were used, and on all 15 trials identified. The results were similar, but the data varied more.

Conclusion:  Bronchodilators produce modest shortterm improvement in clinical features of mild or moderately severe bronchiolitis.Arch Pediatr Adolesc Med. 1996;150:1166-1172

×